Neostigmine product for NMBA reversal approved by FDA

Am J Health Syst Pharm. 2013 Jul 15;70(14):1184. doi: 10.2146/news130048.
No abstract available

Publication types

  • News

MeSH terms

  • Drug Approval*
  • Humans
  • Neostigmine / administration & dosage*
  • Neuromuscular Blockade / adverse effects*
  • Neuromuscular Nondepolarizing Agents / adverse effects*
  • Parasympathomimetics / administration & dosage
  • United States

Substances

  • Neuromuscular Nondepolarizing Agents
  • Parasympathomimetics
  • Neostigmine